Biggest Health And Life Sci Rulings Of 2019: Midyear Report
By Jeff Overley · June 21, 2019, 7:44 PM EDT
Already a subscriber? Click here to login
Analysis
By Jeff Overley · June 21, 2019, 7:44 PM EDT
Already a subscriber? Click here to login
United States Of America v. Novartis Pharmaceuticals Corporation
New York Southern
Other Statutory Actions
January 05, 2011
COMMONWEALTH OF PENNSYLVANIA v. TRUMP et al
Pennsylvania Eastern
Civil Rights: Other
October 11, 2017
In Re: National Prescription Opiate Litigation
Ohio Northern
P.I.: Other
November 04, 2022
District Of Columbia
Other Statutory Actions
January 24, 2018
Illinois Southern
Qui Tam (31 U.S.C. § 3729(a))
July 20, 2017
Alex M. Azar, II, Secretary of Health and Human Services, Petitioner v. Allina Health Services, et al.
Supreme Court
2151 Ovrpmnts Under the Medicare Act
April 30, 2018
STATE OF NEW YORK et al v. UNITED STATES DEPARTMENT OF LABOR et al
District Of Columbia
Administrative Procedure Act/Review or Appeal of Agency Decision
July 26, 2018
District Of Columbia
Other Statutory Actions
August 14, 2018
SMSPF, LLC et al v. EMD SERONO, INC. et al
Pennsylvania Eastern
Other Statutes: False Claims Act
October 21, 2016
State of Maryland v. United States of America et al
Maryland
Other Statutory Actions
September 13, 2018
Texas Northern
Civil Rights: Other Civil Rights
October 06, 2018
June 29, 2024
Chevron's End Is Just The Start For Energized Agency FoesJune 17, 2024
Teva, DOJ Signal Key Kickback Case May Fizzle At 1st Circ.March 29, 2024
Hogan Lovells Vet's High Court Debut A Study In ContrastsJanuary 29, 2024
The Top Attys In Clinton's Impeachment Trial, 25 Years LaterJanuary 18, 2024
'Chaos' Warning Resonates As Justices Mull Chevron's FateJanuary 01, 2024
Appellate Outlook: Circuit Splits & Hot Topics To Track In 2024December 09, 2023
Circuit-By-Circuit Guide To 2023's Most Memorable MomentsNovember 09, 2023
Paul Clement's Big Idea: Overrule Chevron, Ease PolarizationOctober 27, 2023
Are Justices Split 3-3-3? New Term Is Already Offering CluesOctober 18, 2023
Novartis Airs Mea Culpa As 2nd Circ. Probes Kickback Theory